Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 30 (4), 895-901

Hyperinsulinemia in Newly Diagnosed Patients With Multiple Sclerosis


Hyperinsulinemia in Newly Diagnosed Patients With Multiple Sclerosis

Adela Penesova et al. Metab Brain Dis.


There are limited data regarding glucose metabolism dysregulation in multiple sclerosis (MS). Present study investigates glucose and insulin response during oral glucose tolerance test (oGTT) in MS patients. We examined 19 MS patients and 19 age, sex and body mass index (BMI) matched healthy controls. MS patients were newly diagnosed, untreated and with low Expanded Disability Status Scale (EDSS) score (1.1 ± 0.7). Plasma glucose, lactate, insulin and GLP-1 during oGTT, and fasting adipokines, lipid and inflammatory parameters were analyzed. Insulin sensitivity indices (ISI) were calculated. MS patients had comparable fasting (5.2 ± 0.3 vs. 5.0 ± 0.4 mmol/l, p = 0.05) and post-load glucose concentrations as controls. Insulin response to oral glucose load in MS was increased (p = 0.022). Insulin sensitivity was lower in MS compared to controls [ISI(Matsuda) 6.95 ± 3.44 vs. 10.60 ± 4.81, p = 0.011 and ISI(Cederholm) 49.9 ± 15.3 vs. 61.3 ± 16.3, p = 0.032]. We did not find any difference in lactate, GLP-1, total, HDL and LDL cholesterol, triglycerides, interleukin 6, tumor necrosis factor, C-reactive protein, resistin, leptin, adiponectin levels between groups. We found decreased insulin sensitivity with postprandial hyperinsulinemia in MS patients, which seems not to be related to chronic inflammation or physical inactivity. The role of hyperinsulinemia in CNS function impairment should be further investigated.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles


    1. Eur J Epidemiol. 2010 Nov;25(11):777-88 - PubMed
    1. Ann N Y Acad Sci. 2008 Dec;1148:490-4 - PubMed
    1. Lancet. 2008 Oct 25;372(9648):1502-17 - PubMed
    1. Diabetes Care. 1998 Apr;21(4):518-24 - PubMed
    1. Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1112-23 - PubMed

Publication types